Skip to main content
. 2021 Mar 28;61(3):821–831. doi: 10.47162/RJME.61.3.20

Table 2.

Distribution of α-SMA and Shh immunoexpression levels in primary and recurrent BCCs

Description of sample/diagnosis

Antigens

Location

α-SMA

Shh

Weak

Moderate

Strong

Weak

Moderate

Strong

Primary BCC

Tumor

627 (58.0%)

274 (25.3%)

181 (16.7%)

347 (33.2%)

344 (32.9%)

355 (33.9%)

Recurrent BCC

195 (60.2%)

52 (16.0%)

77 (23.8%)

96 (30.8%)

101 (32.5%)

114 (36.7%)

Primary BCC

Stroma

914 (75.2%)

216 (17.8%)

85 (7.0%)

929 (76.1%)

223 (18.3%)

68 (5.6%)

Recurrent BCC

243 (67.5%)

60 (16.7%)

57 (15.8%)

259 (72.0%)

67 (18.6%)

34 (9.4%)

α-SMA: Alpha-smooth muscle actin; BCC: Basal cell carcinoma; Shh: Sonic hedgehog. *The shown numerical data represent the number of visual fields estimated and demonstrated either weak or moderate and strong expression of antigen